T HE regulation of gonadotropin secretion in the human involves a complex interplay between stimulation by GnRH from the hypothalamus, inhibitory feedback by sex steroids and inhibin(s) from the gonads, and autocrine/paracrine modulation by activin and follistatin within the pituitary. It was initially believed that two different hypothalamic factors regulated the secretion of LH and FSH. However, it is now generally accepted that GnRH is the stimulating factor for both hormones and that any divergence in their secretion can be explained by differential sensitivities of LH and FSH to variations in the dose or frequency of pulsatile GnRH secretion, the gonadal hormonal milieu including sex steroid and nonsteroidal factors, and/or alterations in the pituitary tone of activin and/or follistatin. The nonsteroidal regulation of FSH in the human is mediated by the opposing effects of inhibin and activin, with inhibin selectively suppressing, and activin stimulating, FSH release (1). Follistatin, although structurally unrelated to inhibin, also suppresses FSH secretion by binding to activin, thereby modulating its bioavailability. It is the purpose of this review to provide perspective on the endocrine role of gonadal inhibin A and inhibin B in the differential control of LH and FSH secretion in the human, although data from the nonhuman primate will be included to address issues not yet studied in the human.